Business Description
Bioasis Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA09064N1033
Compare
Compare
Traded in other countries / regions
BTI.CanadaBIOAF.USA107.Germany IPO Date
2009-04-15Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | -1.53 | |||||
| Debt-to-Equity | -0.82 | |||||
| Debt-to-EBITDA | -0.71 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -39.66 | |||||
| Beneish M-Score | 1.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -65.8 | |||||
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 4.3 | |||||
| 3-Year Book Growth Rate | -42.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.45 | |||||
| 9-Day RSI | 38.59 | |||||
| 14-Day RSI | 41.37 | |||||
| 6-1 Month Momentum % | -77.98 | |||||
| 12-1 Month Momentum % | -97.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.11 | |||||
| Quick Ratio | 0.11 | |||||
| Cash Ratio | 0.04 | |||||
| Days Sales Outstanding | 99.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | -7.39 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1143.12 | |||||
| Net Margin % | -1069.14 | |||||
| ROA % | -135.07 | |||||
| ROIC % | -131.05 | |||||
| ROC (Joel Greenblatt) % | -322300 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.5 | |||||
| EV-to-EBIT | -0.88 | |||||
| EV-to-EBITDA | -0.91 | |||||
| EV-to-Revenue | 10.6 | |||||
| EV-to-FCF | -1.47 | |||||
| Earnings Yield (Greenblatt) % | -113.64 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOAF
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioasis Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.204 | ||
| EPS (TTM) ($) | -0.025 | ||
| Beta | 0.15 | ||
| Volatility % | 115.38 | ||
| 14-Day RSI | 41.37 | ||
| 14-Day ATR ($) | 0.001162 | ||
| 20-Day SMA ($) | 0.00499 | ||
| 12-1 Month Momentum % | -97.05 | ||
| 52-Week Range ($) | 0.0036 - 0.1843 | ||
| Shares Outstanding (Mil) | 79.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioasis Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioasis Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioasis Technologies Inc Frequently Asked Questions
What is Bioasis Technologies Inc(BIOAF)'s stock price today?
The current price of BIOAF is $0.00. The 52 week high of BIOAF is $0.18 and 52 week low is $0.00.
When is next earnings date of Bioasis Technologies Inc(BIOAF)?
The next earnings date of Bioasis Technologies Inc(BIOAF) is .
Does Bioasis Technologies Inc(BIOAF) pay dividends? If so, how much?
Bioasis Technologies Inc(BIOAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers